composition, inhaler, single dosage form, particle manufacturing methods, to improve respiratory infection-induced exacerbations of a respiratory disorder, to prevent respiratory infection-induced exacerbations of a respiratory disorder, to reduce the incidence of respiratory infection-induced exacerbations of a respiratory disorder, to reduce the severity of respiratory infection-induced exacerbations of a respiratory disorder, to prevent a viral respiratory infection, and to manufacture a controlled ribavirin dry powder inhalation particle in crystalline polymorph form, manufactured particle

• 收藏
• 分享

专利权人:

LIQUIDIA TECHNOLOGIES, INC.;GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED

发明人:

BRIAN T. FARRER,CHRISTOPHER D. ROBERTS,JACOB J. SPRAGUE,JOHN ROBERT SAVAGE,PHILIP CHARLES DELL'ORCO,YONGCAI WANG,ZHI HONG,PHILIP CHARLES DELLORCO

申请号：

BR112018009899

公开号：

BR112018009899A2

申请日:

2016.11.18

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

Inhalable antiviral ribavirin pharmaceutical compositions, methods of producing them, and the use of such compositions in the treatment of virally associated respiratory infections, and associated diseases and conditions are disclosed.são divulgadas as composições farmacêuticas antivirais inaláveis de ribavirina, os métodos de produzir as mesmas, e o uso de tais composições no tratamento de infecções respiratórias viralmente associadas, e doenças e condições associadas.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/